Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid

EU orphan designation number: EU/3/13/1100   
Active ingredient: Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid
Indication: Treatment of amyloid light-chain amyloidosis
Sponsor: Onclave Therapeutics Limited
Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/02/2013 Centralised Orphan - Designation EMA/OD/129/12 (2013)801 of 08/02/2013